ChemoSen3D Competitors and Similar CompaniesClear all
ChemoSen3D's competitors and similar companies include Exagen, Biocrates Life Sciences, SensAbues and Aladdin.
 ChemoSen3D ChemoSen3D (formerly Nano3D Biosciences) is a company that develops an approach to personalized treatment to deliver recommendations. |  Exagen Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. |  Biocrates Life Sciences Biocrates Life Sciences is a developer of targeted metabolic phenotyping solutions. | |||
Founding Date | Founding Date 2008 | Founding Date 2002 | Founding Date 2002 | Founding Date 2009 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Houston, US HQ | Locations Vista, US HQ | Locations Innsbruck, AT HQ | Locations Stockholm, SE HQ Västerås, SE | Locations HQ |
Employees | Employees 5 | Employees 144 | Employees 593% decrease | Employees 1 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 45 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 24.7 k |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $66.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $27.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $38.8m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($20m) (FY, 2025) | Net income N/A | Net income N/A | Net income (€1.2m) (FY, 2020) |
Funding | |||||
Latest funding round | Latest funding round $ 250k (almost 16 years ago) | Latest funding round N/A | Latest funding round $ 956k (over 10 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 49.6m | Total funding raised $ 14.2m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Exagen
HQ
Vista, US
Employees
144
Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention.
View companyBiocrates Life Sciences
HQ
Innsbruck, AT
Employees
59↓ 3% decrease
Biocrates Life Sciences is a developer of targeted metabolic phenotyping solutions.
View company
SensAbues
HQ
Stockholm, SE
Employees
1
SensAbues is a company specializing in the drug detection and health monitoring.
View company